Form D · Other Health Care
Parexel International Corp
Durham, NY · CIK 0001892518
Offering snapshot reported Oct 21, 2024 · SEC filing
- Reported sold
- Yet to sell Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 21, 2024 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Nov 15, 2021 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-527260
Source: Form D, filed Oct 21, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John R. J. Benoit | Director, Executive |
| Michael F. Crowley, Iii | Director, Executive |
| Nicholas Curwen | Executive |
| W. Brett Davis | Executive |
| Julie Gilbert | Director |
| Thomas Spicer | Executive |
| Marie Louise Van Dam | Executive |
| Ethan Waxman | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2520 Meridian Parkway
Durham, NY, 27713
Durham, NY, 27713